Skip to main content
See every side of every news story
Published loading...Updated

New Study Identifies Surprising Marker in Kidney Disease

Summary by BIOENGINEER.ORG
In a groundbreaking study led by University of Texas at Arlington (UTA) researcher Paul J. Fadel, new insights have emerged challenging long-held beliefs about vascular health markers in patients with chronic kidney disease (CKD). For decades, the biomedical community focused on asymmetric dimethylarginine (ADMA) as a critical blood biomarker signaling the risk of vascular complications. […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BIOENGINEER.ORG broke the news in on Thursday, October 2, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal